Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,240 | 3,232 | 7,571 | 13,382 | 53,961 |
| Receivables | 1,000 | 556 | N/A | 96 | 100 |
| Other current assets | 11 | 16 | 11 | 537 | 468 |
| TOTAL | $4,635 | $4,225 | $8,024 | $14,820 | $55,457 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 65 |
| Investments And Advances | 5,350 | 5,350 | 5,350 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 3,259 | 3,809 |
| TOTAL | $5,350 | $5,350 | $5,350 | $3,259 | $3,874 |
| Total Assets | $9,985 | $9,575 | $13,374 | $18,079 | $59,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 508 | 390 | 1,198 | 2,970 | 1,828 |
| Accrued Expenses | 392 | 335 | 888 | 4,657 | 9,257 |
| TOTAL | $900 | $725 | $2,086 | $7,627 | $11,085 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $900 | $725 | $2,086 | $7,627 | $11,085 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,330 | 2,710 | 2,710 | 2,176 | 2,171 |
| Retained earnings | -271,020 | -267,492 | -264,417 | -259,154 | -215,076 |
| Other shareholders' equity | 0 | 0 | -12 | -20 | -23 |
| TOTAL | $9,085 | $8,850 | $11,288 | $10,452 | $48,246 |
| Total Liabilities And Equity | $9,985 | $9,575 | $13,374 | $18,079 | $59,331 |